Thomas M Beaver, MD, MPH - Research

Research at a glance

Top areas of exploration

Aortic Aneurysm, Thoracic , 37 publications
Blood Vessel Prosthesis Implantation , 31 publications
Postoperative Complications , 29 publications
Cardiac Surgical Procedures , 26 publications

Research activity

210 publications

3,345 citations

Why is this important?

Active clinical trials

LeAPPS

This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic鈥�

Investigator: Thomas M Beaver
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

HEAL-IST

Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a鈥�

Investigator: Thomas M Beaver
Status: Accepting Candidates
Ages: 18 Years - 75 Years
Sexes: All

SUMMI-CS0004-P

Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the鈥�

Investigator: Thomas M Beaver
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

210 publications

2023

Commentary: Thoracic endovascular aortic repair in Marfan syndrome-dancing with dogma.

The Journal of thoracic and cardiovascular surgery

鈥�

2023

Discussion to: False lumen-dependent segmental arteries are associated with spinal cord injury in frozen elephant trunk procedure for acute type I aortic dissection.

JTCVS open

鈥�

2023

Dysphagia after cardiac surgery: Prevalence, risk factors, and associated outcomes.

The Journal of thoracic and cardiovascular surgery

鈥�

2023

Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.

Trials

鈥�

2023

Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement With RESILIA Tissue.

The Annals of thoracic surgery

鈥�

BOB体育